XML 193 R19.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Shareholders' Equity
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Shareholders' Equity Shareholders' Equity

Common Shares

The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated:
 
Common Shares
 
(shares in millions) 
Issued
 
Held in Treasury
 
Outstanding
 
Balance, January 1, 2017
268.0

 
73.4

 
194.6

 
Common Shares issued

*

 

*
Common Shares acquired - share repurchase

 
24.4

 
(24.4
)
 
Share-based compensation programs
2.0

 
0.2

 
1.8

 
Balance, December 31, 2017
270.0

 
98.0

 
172.0

 
Common Shares issued

 

 

 
Common Shares acquired - share repurchase

 
22.8

 
(22.8
)
 
Share-based compensation programs
2.4

 
0.6

 
1.8

 
Balance, December 31, 2018
272.4

 
121.4

 
151.0

 
Common Shares issued
0.1

 

 
0.1

 
Common Shares acquired - share repurchase

 
21.1

 
(21.1
)
 
Share-based compensation programs
3.2

 
0.9

 
2.3

 
Treasury Stock retirement
(135.0
)
 
(135.0
)
 

 
Balance, December 31, 2019
140.7

 
8.4

 
132.3

 

* Less than 0.1.

Dividends declared per share of Common Stock were as follows for the periods indicated:
 
Year Ended December 31,
 
2019
 
2018
 
2017
Dividends declared per share of Common Stock
$
0.32

 
$
0.04

 
$
0.04



Share Repurchase Program

From time to time, the Company's Board of Directors authorizes the Company to repurchase shares of its common stock. These authorizations permit stock repurchases up to a prescribed dollar amount and generally may be accomplished through various means, including, without limitation, open market transactions, privately negotiated transactions, forward, derivative, or accelerated repurchase, or automatic repurchase transactions, including 10b5-1 plans, or tender offers. Share repurchase authorizations typically expire if unused by a prescribed date.
On May 2, 2019, the Board of Directors provided share repurchase authorization, increasing the aggregate of the Company's common stock authorized for repurchase by $500. On October 31, 2019, the Board of Directors provided its most recent share repurchase authorization, increasing the aggregate amount of the Company's common stock authorized for repurchase by $800. The additional share repurchase authorization expires on December 21, 2020 (unless extended), and does not obligate the Company to purchase any shares. The authorization for the share repurchase program may be terminated, increased or decreased by the Board of Directors at any time.

The following table presents repurchases of the Company's common stock through share repurchase agreements with third-party financial institutions for the year ended December 31, 2019 and December 31, 2017. The Company did not enter into any share repurchase agreements in 2018.
2019
Execution Date
 
Payment
 
Initial Shares Delivered
 
Closing Date
 
Additional Shares Delivered
 
Total Shares Repurchased
January 3, 2019
 
$
250

 
5,059,449

 
April 4, 2019
 
290,765

 
5,350,214

April 9, 2019
 
$
236

 
3,593,453

 
June 4, 2019
 
879,199

 
4,472,652

June 19, 2019
 
$
200

 
2,963,512

 
August 6, 2019
 
695,566

 
3,659,078

December 19, 2019
 
$
200

 
2,591,093

 
(1) 
 
(1) 
 
(1) 
(1) This arrangement is scheduled to terminate no later than the end of first quarter of 2020, at which time the Company will settle any outstanding positive or negative share balances based on the daily volume-weighted average price of the Company's common stock.
 
2017
Execution Date
 
Payment
 
Initial Shares Delivered
 
Closing Date
 
Additional Shares Delivered
 
Total Shares Repurchased
March 9, 2017
 
$
150

 

 
April 12, 2017
 
3,986,647

 
3,986,647

December 26, 2017
 
$
500

 
7,821,666

 
March 26, 2018
 
1,947,413

 
9,769,079


The following table presents repurchases of our common stock through open market repurchases for the periods indicated:
($ in millions)
Year Ended December 31,
 
2019
 
2018
 
2017
Shares of common stock
4,926,775

 
20,843,047

 
7,437,994

Payment
$
250

 
$
1,025

 
$
273


Warrants

On May 7, 2013, the Company issued to ING Group warrants to purchase up to 26,050,846 shares of the Company's common stock equal in the aggregate to 9.99% of the issued and outstanding shares of common stock at that date. The exercise price of the warrants at the time of issuance was $48.75 per share of common stock, subject to adjustments, including for stock dividends, cash dividends in excess of $0.01 per share a quarter, subdivisions, combinations, reclassifications and non-cash distributions. The warrants also provide for, upon the occurrence of certain change of control events affecting the Company, an increase in the number of shares to which a warrant holder will be entitled upon payment of the aggregate exercise price of the warrant. The warrants became exercisable to ING Group and its affiliates on January 1, 2017 and to all other holders starting on the first anniversary of the completion of the IPO (May 7, 2014). The warrants expire on the tenth anniversary of the completion of the IPO (May 7, 2023). The warrants are net share settled, which means that no cash will be payable by a warrant holder in respect of the exercise price of a warrant upon exercise, and are classified as permanent equity. They have been recorded at their fair value determined on the issuance date of May 7, 2013 in the amount of $94 as an addition and reduction to Additional-paid-in-capital. Warrant holders are not entitled to receive dividends. On March 12, 2018, ING Group sold its remaining interests in the warrants and no longer owns any warrants.

On December 27, 2019, the Company paid a quarterly dividend of $0.15 per share on its common stock. As a consequence, the exercise price of the warrants to purchase shares of common stock was adjusted to $48.49 per share of common stock and the number of shares of common stock for which each warrant is exercisable has been adjusted to 1.002430429. As of December 31, 2019, no warrants have been exercised.

Preferred Stock

On June 11, 2019, the Company issued 300,000 shares of 5.35% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B ("the Series B preferred stock"), with a $0.01 par value per share and a liquidation preference of $1,000 per share, for aggregate net proceeds of $293. The Company deposited the Series B preferred stock under a deposit agreement with a depositary, which issued interests in fractional shares of the Series B preferred stock in the form of depositary shares ("Depositary Shares") evidenced by depositary receipts; each Depositary Share representing 1/40th interest in a share of the Series B preferred stock.

On September 12, 2018, the Company issued 325,000 shares of 6.125% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A, with a $0.01 par value per share and a liquidation preference of $1,000 per share, for aggregate net proceeds of $319.

The ability of the Company to declare or pay dividends on, or purchase, redeem or otherwise acquire, shares of its common stock will be substantially restricted in the event that the Company does not declare and pay (or set aside) dividends on the Series A and Series B Preferred Stock for the last preceding dividend period.

The Series A and Series B preferred stock are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions. The Company may, at its option, redeem the Series A preferred stock, (a) in whole but not in part, at any time, within 90 days after the occurrence of a "rating agency event," at a redemption price equal to $1,020 per share, plus an amount equal to any dividends per share of preferred stock that have accrued but not been declared and paid for the then-current dividend period to, but excluding, the redemption date and (b) (i) in whole but not in part, at any time within 90 days after the occurrence of a "regulatory capital event" or (ii) in whole or in part, from time to time, on September 15, 2023 or any subsequent "reset date," in each case, at a redemption price equal to $1,000 per share of preferred stock, plus an amount equal to any dividends per share of preferred stock that have accrued but not been declared and paid for the then-current dividend period to, but excluding, such redemption date. The Company may, at its option, redeem the Series B preferred stock, (a) in whole but not in part, at any time, within 90 days after the occurrence of a "rating agency event," at a redemption price equal to $1,020 per share (equivalent to $25.50 per Depositary Share), plus an amount equal to any accrued and unpaid dividends per share that have accrued but not been declared and paid for the then-current dividend period, but excluding, such redemption date and (b) (i) in whole but not in part , at any time, within 90 days after the occurrence of a "regulatory capital event," or (ii) in whole or in part, from time to time, on September 15, 2029 or any reset date, in each case, at a redemption price equal to $1,000 per share of the Series B preferred stock (equivalent to $25.00 per Depositary Share), plus an amount equal to any accrued and unpaid dividends per share that have accrued but not been declared and paid for the then-current dividend period to, but excluding, such redemption date.

A "rating agency event" means that any nationally recognized statistical rating organization that then publishes a rating for the Company amends, clarifies or changes the criteria it uses to assign equity credit to securities like the preferred stock, which results in the lowering of the equity credit assigned to the preferred stock, as applicable, or shortens the length of time that the preferred stock is assigned a particular level of equity credit.
A "regulatory capital event" means that the Company becomes subject to capital adequacy supervision by a capital regulator and the capital adequacy guidelines that apply to the Company as a result of being so subject set forth criteria pursuant to which the preferred stock would not qualify as capital under such capital adequacy guidelines, as the Company may determine at any time, in its sole discretion.
As of December 31, 2019 and December 31, 2018, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows:
 
December 31, 2019
 
December 31, 2018
Series
Issued
 
Outstanding
 
Issued
 
Outstanding
6.125% Non-cumulative Preferred Stock, Series A
325,000

 
325,000

 
325,000

 
325,000

5.35% Non-cumulative Preferred Stock, Series B
300,000

 
300,000

 

 

Total
625,000

 
625,000

 
325,000

 
325,000

As of December 31, 2019, there were no preferred stock dividends in arrears.